Cite
HARVARD Citation
Tomasini, P. et al. (2019). Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases. Therapeutic advances in respiratory disease. p. . [Online].